Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local doxycycline in periodontal regeneration (ANBperio)
NCT07027137Active, not recruiting
- Sponsor
- Medical University of Białystok
- Start
- Aug 2019
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of doxycycline in periodontitis, sponsored by Medical University of Białystok. Primary endpoint: Clinical outcomes following periodontal regeneration at 12 months. Started Aug 2019; status: active, not recruiting.
02
Drugs
doxycycline
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT07027137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07027137.